News & Coverage
Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans
Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a leader in psychedelics-focused mental healthcare, has today announced novel, proprietary methods for psychedelic mushroom compound ...
YAHOO!Finance
Nov 29, 2021
Mindset to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable ...
Yahoo Finance
Nov 29, 2021
Enveric Biosciences to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th
Enveric Biosciences ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules ...
Le Lézard
Nov 29, 2021
Peter Thiel-Backed Psychedelic Start-Up Increases Stake in Compass Pathways
Atai Life Sciences, the Peter Thiel-backed start-up that wants to use psychedelic drugs to treat mental health ... Compass Pathways, which Thiel has also invested in, wants to use psilocybin (the ...
NBC 7 San Diego
Nov 29, 2021
Giving Birth Was Like A 'Wild Acid Trip,' Says Psychedelic Mom And Therapist: Here's Why
This article was originally published on Psychedelic Spotlight Is giving birth a lot like having a mind-bending psychedelic experience? Mother, plant medicine enthusiast, and licensed professional ...
Benzinga.com
Nov 28, 2021
Psychedelics Show Promise in Treating Mental Illness: Depression, Anxiety, Addiction, and PTSD
One in five U.S. adults will experience a mental illness in their lifetime, according to the National Alliance of Mental Health. But standard treatments can be slow to work and cause side effects. To ...
SciTech Daily
Nov 27, 2021
